Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Yusuke Tadayasu"'
Autor:
Yusuke Tadayasu, Akiko Sarashina, Yasuhiro Tsuda, Shinji Tatami, Christian Friedrich, Silke Retlich, Alexander Staab, Mikihisa Takano
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 16, Iss 5 (2013)
[Objectives] Linagliptin is a novel, highly selective and long acting DPP-4 inhibitor for the treatment of type 2 diabetes mellitus (T2DM). Linagliptin exhibits non-linear pharmacokinetics (PK) due to saturable binding to plasma and tissue DPP-4. The
Externí odkaz:
https://doaj.org/article/37eb091a6ac9429eaede04e474fe5e78
Publikováno v:
Pulmonary pharmacologytherapeutics. 63
Background Chronic obstructive pulmonary disease (COPD) is one of the major causes of morbidity and mortality worldwide and in China. For patients with more severe symptoms, initial treatment with long acting β2-agonists and long-acting muscarinic a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::167b2a09b12bdf9a514156dc0affdb4a
https://pubmed.ncbi.nlm.nih.gov/32916296
https://pubmed.ncbi.nlm.nih.gov/32916296
Autor:
Yukihiko Sugiyama, Shinji Abe, Wataru Sakamoto, Yoshikazu Inoue, Arata Azuma, Yasuhiro Kondoh, Matthias Klüglich, Kotaro Okazaki, Tsuyoshi Fujimoto, Yusuke Tadayasu, Yoshiro Mochizuki, Hiroyuki Taniguchi, Masashi Bando, Yoshinori Hasegawa, Takashi Ogura, Kingo Chida
Publikováno v:
European Respiratory Journal. 45:1382-1392
A randomised, double-blind, phase II, dose escalation trial was conducted to assess the safety, tolerability and pharmacokinetics of the tyrosine kinase inhibitor nintedanib, alone and when added to ongoing pirfenidone therapy, in Japanese patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb8570e495b96b3e653e82288f33c3b5
https://doi.org/10.1183/09031936.00198013
https://doi.org/10.1183/09031936.00198013
Autor:
Eric D. Bateman, Carnelia Schepers, Alison Mackie, Yusuke Tadayasu, Chester C. Wood, Jiyeong Maria Kim, Ganghyuck Lee, Benjamin Weber, Ewald Benediktus
Publikováno v:
5.1 Airway Pharmacology and Treatment.
Introduction: BI 1060469, a novel oral antagonist of the chemo-attractant receptor-homologous molecule on T-helper-2 cells (CRTH2), targets airway inflammation in asthma by inhibiting prostaglandin D 2 (PGD 2 ) binding to CRTH2. Aim: Investigate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd0b328cd8d05a1a2fbcd462276d33cc
https://doi.org/10.1183/13993003.congress-2016.pa4125
https://doi.org/10.1183/13993003.congress-2016.pa4125
Autor:
Alexander Staab, Karl Heinz Liesenfeld, Shun Higuchi, Norio Yamamura, Ichiro Ieiri, Hans Günter Schäfer, Shinji Tatami, Yasuhiro Tsuda, Yusuke Tadayasu, Akiko Sarashina
Publikováno v:
British Journal of Clinical Pharmacology. 70:88-101
AIMS The main objective of this study was to characterize the population pharmacokinetics of tamsulosin hydrochloride (HCl) in paediatric patients with neuropathic and non-neuropathic bladder. A secondary objective was to compare the pharmacokinetics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d8611b87109784a883554c7ec43ff4b
https://doi.org/10.1111/j.1365-2125.2010.03662.x
https://doi.org/10.1111/j.1365-2125.2010.03662.x
Autor:
Alexander Staab, Shinji Tatami, Yusuke Tadayasu, Yasuhiro Tsuda, Silke Retlich, Mikihisa Takano, Christian Friedrich, Akiko Sarashina
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 16, Iss 5 (2013)
[Objectives] Linagliptin is a novel, highly selective and long acting DPP-4 inhibitor for the treatment of type 2 diabetes mellitus (T2DM). Linagliptin exhibits non-linear pharmacokinetics (PK) due to saturable binding to plasma and tissue DPP-4. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7aff0eff78f8c9c79a2081db13e34e6
https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/20477
https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/20477
Autor:
Yasuhiro, Tsuda, Shinji, Tatami, Norio, Yamamura, Yusuke, Tadayasu, Akiko, Sarashina, Karl-Heinz, Liesenfeld, Alexander, Staab, Hans-Günter, Schäfer, Ichiro, Ieiri, Shun, Higuchi
Publikováno v:
British journal of clinical pharmacology. 70(1)
Tamsulosin is available on prescription as a modified release capsule in the US (Flomax), and in most European countries for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). The pharmacokinetics of tamsulosin hydrochlori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1d38090ee0087a6f59857b2229991f4e
https://pubmed.ncbi.nlm.nih.gov/20642551
https://pubmed.ncbi.nlm.nih.gov/20642551
Autor:
Alan Hamilton, Toshiyasu Izumoto, Ayako Takizawa, Yoshinosuke Fukuchi, Yusuke Tadayasu, Christina Kunz, Masakazu Ichinose
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Masakazu Ichinose,1 Ayako Takizawa,2 Toshiyasu Izumoto,2 Yusuke Tadayasu,2 Alan L Hamilton,3 Christina Kunz,4 Yoshinosuke Fukuchi51Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan; 2Nippon Boehringer In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7973767ee2b888070d5b580e0549c5f5
https://doi.org/10.2147/copd.s86002
https://doi.org/10.2147/copd.s86002
Autor:
Masakazu Ichinose, Ayako Takizawa, Toshiyasu Izumoto, Yusuke Tadayasu, Hamilton, Alan L., Kunz, Christina, Yoshinosuke Fukuchi
Publikováno v:
International Journal of COPD; 10/8/2015, p1673-1683, 11p